MJoTA.org

Medical Writing Institute - Emerald Pademelon Press LLC - Peace Scientists

Welcome

Food and health

Drinking sugar

Bad drugs

Breaking a leg

GWRAZ

Medical Writing Institute

Writing for MJoTA

International training

MiMW1 Medical writing

Information podcasts

MWI Certificate

MWI links

Grammar

PowerPoint Presentations

Presenting yourself

Registration page

Malaria

201205MalariaDrugResistan

201205Malaria vaccine ph1

201205 Malaria bad drugs

Malaria Podcasts

Ebola

Alcohol

Polio

Polio vaccines refused

Small pox WHO

HIV/AIDS

HIV/AIDS Podcasts

BI HIV drug

CDC HIV

Asthma

20120501 Asthma home

20120501 Asthma US Africa

20120501 NIH asthma

Diabetes

Diabetes CME resources

Diabetes Podcasts

Oats

White rice, white bread

Diabetes cinnamon rats

Diabetes cinnamon

Diabetes cinnamon EJI

Diabetes cinnamon lipids

Diabetes nutmeg

20120517 Coffee NEJM

20120517coffee alzheimers

20120517 Coffee Japan

Amer J Diabetes

20120612antidiabeticPlant

20120619 oats UK

20120619 oats Ulster

20120618 oats sweden

20120618 oats brazil

20120618 oats canada

Liver

Cancer

Cancer Podcasts

Tuberculosis

Physical abuse

Ganymede Movies LLP

MJoTAtalks: Health

MJoTA pages

Search page

MJoTA masthead

Author guidelines

MJoTA publications

Front covers

Tropical diseases movies

Health Audio Podcasts

Caribbean Health Podcasts

African Health Dialogues

African Health Podcasts

Child Health Podcasts

Contact us

 
Loading

Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.

Rolling T, Schmiedel S, Wichmann D, Wittkopf D, Burchard GD, Cramer JP. Malar J. 2012 May 17;11(1):169.

Abstract

ABSTRACT: Parenteral artesunate has been shown to be a superior treatment option compared to parenteral quinine in adults and children with severe malaria. Little evidence, however, is available on long-term safety. Recently, cases of late-onset haemolysis after parenteral treatment with artesunate have been reported in European travellers with imported Plasmodium falciparum malaria. Therefore, an extended follow-up of adult patients treated for severe imported malaria was started in August 2011 at the University Medical Center Hamburg-Eppendorf. Until January 2012, three patients with hyperparasitaemia (range: 14-21%) were included for analysis. In all three patients, delayed haemolysis was detected in the second week after the first dose of intravenous artesunate. Reticulocyte production index remained inadequately low in the 7 - 14 days following the first dose of artesunate despite rapid parasite clearance. Post-treatment haemolysis after parenteral artesunate may be of clinical relevance in particular in imported severe malaria characterized by high parasite levels. Extended followup of at least 30 days including controls of haematological parameters after artesunate treatment seems to be indicated. Further investigations are needed to assess frequency and pathophysiological background of this complication.


MJoTA has been published since 2006 by Emerald Pademelon Press LLC. PO Box 381 Haddonfield, NJ 08033, USA. MJoTA.org and drsusanna.org hosts MJoTA, and the Medical Writing Institute, which is a New Jersey nonprofit corporation. All inquiries for the Medical Writing Institute or Emerald Pademelon Press LLC: 01-609-792-1571; publisher@mjota.org. Contact the publisher directly through Facebook click here